SB606
Interim Study (House)relative to insurance coverage for biomarker testing.
Status
Hearing
No upcoming hearing scheduled.
Testimony
43 total submissions
Bill Docket
Refer for Interim Study: MA VV 05/14/2026 HJ 13
HouseMay 14, 2026
Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 8
HouseMay 01, 2026
Executive Session: 04/29/2026 10:00 am GP 229
HouseApril 22, 2026
Subcommittee Work Session: 04/28/2026 10:00 am GP 229
HouseApril 22, 2026
Subcommittee Work Session: 04/22/2026 10:00 am GP 229
HouseApril 16, 2026
Subcommittee Work Session: 04/08/2026 10:00 am GP 229
HouseApril 01, 2026
Public Hearing: 04/01/2026 11:00 am GP 229
HouseMarch 24, 2026
Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8
HouseMarch 16, 2026
Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6
SenateMarch 06, 2026
Committee Report: Ought to Pass, 03/12/2026; Vote 7-0; CC; SC 9
SenateMarch 05, 2026
Ought to Pass with Amendment #2026-0689s, MA, VV; Refer to Finance Rule 4-5; 02/19/2026; SJ 4
SenateFebruary 18, 2026
Committee Amendment # 2026-0689s, AA, VV; 02/19/2026; SJ 4
SenateFebruary 12, 2026
Committee Report: Ought to Pass with Amendment # 2026-0689s, 02/19/2026; Vote 5-0; CC; SC 6
SenateFebruary 12, 2026
Hearing: 01/28/2026, Room 100, SH, 09:00 am; SC 3
SenateJanuary 22, 2026
Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1
SenateNovember 25, 2025